Variant position: 983 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 2009 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human AGQAMCLTVFMMVMVIGNLV VLNLFLALLLSSFSADNLAAT
Mouse AGQAMCLTVFMMVMVIGNLV VLNLFLALLLSSFSADNLAAT
Rat AGQAMCLTVFMMVMVIRNLV VLNLFLALLLSSFSADNLAAT
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 2009 Sodium channel protein type 1 subunit alpha
971 – 991 Helical; Name=S6 of repeat II
750 – 1022 II
Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.
Fujiwara T.; Sugawara T.; Mazaki-Miyazaki E.; Takahashi Y.; Fukushima K.; Watanabe M.; Hara K.; Morikawa T.; Yagi K.; Yamakawa K.; Inoue Y.;
Cited for: VARIANTS EIEE6 GLY-103; ILE-112; TRP-265; ASP-343; VAL-960; ILE-985; ARG-1231; LEU-1263; ASP-1685; 1807-MET--GLU-1810 DEL; GLY-1812 AND SER-1831; VARIANTS ICEGTC SER-808; ARG-979; ALA-983; ILE-1011; PHE-1611; SER-1632; ILE-1709 AND LEU-1808; VARIANT THR-1067;
Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures.
Rhodes T.H.; Vanoye C.G.; Ohmori I.; Ogiwara I.; Yamakawa K.; George A.L. Jr.;
J. Physiol. (Lond.) 569:433-445(2005)
Cited for: VARIANTS ICEGTC SER-808 AND ILE-1011; CHARACTERIZATION OF VARIANTS ICEGTC SER-808; ARG-979; ALA-983; ILE-1011; PHE-1611; SER-1632; ILE-1709 AND LEU-1808;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.